$2.440
+0.242 (+9.91%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de ATHE por análisis de gráficos similares
Alphio's ATHE stock price prediction model matches the current Alterity Therapeutics Limited tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $2.47 (+1.16%). The 1-week path is $2.45 (+0.25%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Alterity Therapeutics Limited?
Alterity Therapeutics is not a strong buy right now due to its current price of $2.09, which is significantly below the analyst price targets of $10 to $16. The RSI is at 24, indicating oversold conditions, but the stock has a high risk with a 20-day change of -35.09%, suggesting recent volatility. While positive FDA feedback for ATH434 is promising, the stock's performance reflects market skepticism and a lack of momentum.
ATHE cerró en $2.44 el Friday, tras subir +9.91%
Alterity Therapeutics Limited (ATHE) last closed at $2.4400001, gaining +9.91%. These facts feed the 1-day and 1-week ATHE price prediction above.
Factores de la previsión
Los factores de la previsión de Alterity Therapeutics Limited (ATHE) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bearish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de ATHE, ordenadas por similitud.
Análisis de estacionalidad de ATHE
Historically the probability of a positive November return for ATHE is 15.91%. June offers the highest probability of a positive month at 68.33%, while December is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de ATHE
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Nov 2026 | $4.99 | $5.39 | $6.43 | +120.79% |
| Dec 2026 | $4.13 | $4.94 | $5.55 | +102.61% |
En 2026, se proyecta que Alterity Therapeutics Limited (ATHE) oscile entre $4.13 y $6.43.
Previsión mensual de Alterity Therapeutics Limited para 2026
En Nov de 2026, se proyecta que Alterity Therapeutics Limited promedie $5.39, con un mínimo de $4.99 y un máximo de $6.43.
En Dec de 2026, se proyecta que Alterity Therapeutics Limited promedie $4.94, con un mínimo de $4.13 y un máximo de $5.55.
Artículos relacionados
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.